These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4396715)

  • 1. Biopharmaceutical studies on 4-(aminoethanesulfonylamino)antipyrine and related compounds. I.
    Naito SI; Ueno Y; Yamaguchi H; Nakai T
    J Pharm Sci; 1971 Feb; 60(2):245-9. PubMed ID: 4396715
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-(Aminoethanesulfonylamino)thiazole and related compounds. I. Stability, absorption, excretion, and some pharmacological activities.
    Naito SI; Shimizu S
    J Pharm Sci; 1973 Jan; 62(1):82-7. PubMed ID: 4405050
    [No Abstract]   [Full Text] [Related]  

  • 3. Biopharmaceutical studies on aminoethanesulfonylphenetidine and related compounds. II.
    Naito SI; Fukui K
    J Pharm Sci; 1971 Feb; 60(2):249-55. PubMed ID: 4396716
    [No Abstract]   [Full Text] [Related]  

  • 4. 4(beta-benzoylvinyl)-antipyrine derivatives after antiphlogistic and analgesic activity.
    Massarani E; Nardi D; Magistretti MJ
    Arzneimittelforschung; 1969 Dec; 19(12):2020-2. PubMed ID: 5395897
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopharmaceutical studies of oral formulations containing propyphenazone.
    Shekerdjiiski R; Paskov V; Lambov N; Gencheva P; Rachev D; Titeva S; Minkov E
    Pharmazie; 1987 Mar; 42(3):184-6. PubMed ID: 3602076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-phenylglioxylidenamino-antipyrine with antiphlogistic and analgesic activity.
    Nardi D; Massarani E; Magistretti MJ
    Arzneimittelforschung; 1969 Dec; 19(12):2026-7. PubMed ID: 4985339
    [No Abstract]   [Full Text] [Related]  

  • 7. Biopharmaceutical studies on guaiacol glyceryl ether and related compounds. V.
    Naito SI; Mizutani M; Osumi S; Mikawa T; Sekishiro K; Nakao K; Wakita H
    J Pharm Sci; 1972 Aug; 61(8):1212-5. PubMed ID: 4403205
    [No Abstract]   [Full Text] [Related]  

  • 8. [The pharmacologic properties of stearic acid antipyrylamide (stampyrine)].
    Saratikov AS; Prishchep TP; Stepnova GM; Shmidt EV; Borisova GV
    Farmakol Toksikol; 1972; 35(6):723-7. PubMed ID: 4651810
    [No Abstract]   [Full Text] [Related]  

  • 9. [The combined effects of N-butylscopolamine bromide and sulpyrin. I. Antispasmodic activity, analgesic activity and acute toxicity].
    Uesaka I; Kubo S; Ishiwatari M; Tanaka K; Noguchi Y
    Yakugaku Zasshi; 1973 Mar; 93(3):283-6. PubMed ID: 4353460
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism of drugs. 58. Metabolism of butylaminoantipyrine].
    Yoshimura H; Shimeno H; Tsukamoto H
    Yakugaku Zasshi; 1968 Jan; 88(1):89-93. PubMed ID: 5692291
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of anti-inflammatory drugs on vascular smooth muscle.
    Northover BJ
    Br J Pharmacol Chemother; 1967 Nov; 31(3):483-93. PubMed ID: 4384259
    [No Abstract]   [Full Text] [Related]  

  • 12. Isolation and purification of three glucuronides of antipyrine. Proposal for an original analytical method for quantitation of sulpho- and glucuroconjugated metabolites.
    Palette C; Cordonnier P; Tillequin F; Koch M; Advenier C; Pays M
    Biomed Chromatogr; 1994; 8(2):77-84. PubMed ID: 8044026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liothyronine-induced hypermetabolism on dipyrone metabolism in man.
    Brunk SF; Combs SP; Miller JD; Delle M; Wilson WR
    J Clin Pharmacol; 1973; 13(5):210-3. PubMed ID: 4350903
    [No Abstract]   [Full Text] [Related]  

  • 14. Bradykinin induced bronchoconstriction in guinea pigs and its modification by various agents.
    Simke J; Graeme ML; Sigg EB
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):291-301. PubMed ID: 4382225
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.
    Buchanan N; Davis M; Danhof M; Breimer DD
    Br J Clin Pharmacol; 1980 Oct; 10(4):363-8. PubMed ID: 7448107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical safety assessment of antipyrine combined with lidocaine hydrochloride as ear drops.
    Zou YX; Feng X; Chu ZY; Liu WH; Zhang XD; Ba JB
    Regul Toxicol Pharmacol; 2019 Apr; 103():34-40. PubMed ID: 30634025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological activities of isopropylantipyrine derivatives, ephedrine-isopropylantipyrine and metabolism of its tritium labeled compound (author's transl)].
    Aonuma S; Koamay Y; Chen I; Yashiki S
    Yakugaku Zasshi; 1975 Feb; 95(2):151-61. PubMed ID: 1170294
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric ulcerogenic and biological activities of N-3'a-propyphenazonyl-2-acetoxybenzamide.
    Aonuma S; Kohama Y; Komiyama Y; Fujimoto S
    Chem Pharm Bull (Tokyo); 1980; 28(4):1237-44. PubMed ID: 6968250
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.
    Danhof M; Breimer DD
    Br J Clin Pharmacol; 1979 Dec; 8(6):529-37. PubMed ID: 533575
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental establishment of the maximum permissible concentration of phenazone in the air of a work area].
    Pastushenko TV; Manenko AK
    Gig Tr Prof Zabol; 1979 Aug; (8):48-50. PubMed ID: 488730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.